Alex Makhnin

ORCID: 0000-0003-1998-7274

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer”.

Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

Nature Communications(2021)10.1038/s41467-021-23912-4

N/A

1.1DataRank · unranked

34 citations

Adam J. Schoenfeld, Alex Makhnin, Yosef Y. Tobi, Yuli Wang, Heidie Frisco Cabanos +10 more

Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR -Mutant Lung Adenocarcinomas

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3484

N/A

0.165DataRank · unranked

2 citations

Alex Makhnin, Khadeja A. Moses, Linda S. Ahn, Isabel R. Preeshagul, Afsheen N. Iqbal +9 more

Multiplex SuperSelective PCR Assays for the Detection and Quantitation of Rare Somatic Mutations in Liquid Biopsies

Journal of Molecular Diagnostics(2021)10.1016/j.jmoldx.2021.11.006

N/A

0DataRank · unranked

2 citations

Sanjay Tyagi, Salvatore A. E. Marras, Patricia Moerzinger, Juan Andrés Abin‐Carriquiry, Mauricio Cuello +9 more

Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancer

Translational Lung Cancer Research(2022)10.21037/tlcr-22-164

N/A

0DataRank · unranked

7 citations

Michael Offin, Jessica Flynn, Zhigang Zhang, Emily S. Lebow, Khaled Aziz +9 more

A Phase II Study of Cabozantinib in Patients With MET-Altered Lung Cancers

JTO Clinical and Research Reports(2025)10.1016/j.jtocrr.2025.100857

N/A

0DataRank · unranked

0 citations

Fernando C. Santini, Clare Wilhelm, Rebecca W Repetti, Jason C. Chang, Soo-Ryum Yang +10 more